Cargando…
An ETV6-ABL1 fusion in a patient with chronic myeloproliferative neoplasm: Initial response to Imatinib followed by rapid transformation into ALL
We report the case of a 26 year-old patient presenting with a persistent leukocytosis and CML-like marrow but no evidence of a BCR/ABL1 fusion. Molecular cytogenetics revealed that a portion of the ETV6 locus was inserted into the ABL1 locus. An ETV6/ABL1 fusion transcript could subsequently be conf...
Autores principales: | Kakadia, Purvi M., Schmidmaier, Ralf, Völkl, Andreas, Schneider, Irene, Huk, Natalia, Schneider, Stephanie, Panzner, Gerda, Neidel, Ulrike, Fritz, Barbara, Spiekermann, Karsten, Bohlander, Stefan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078675/ https://www.ncbi.nlm.nih.gov/pubmed/27812500 http://dx.doi.org/10.1016/j.lrr.2016.09.002 |
Ejemplares similares
-
Myeloproliferative neoplasm with ETV6-ABL1 fusion: a case report and literature review
por: Gancheva, Katya, et al.
Publicado: (2013) -
Myeloproliferative Neoplasm Driven by ETV6-ABL1 in an Adolescent with Recent History of Burkitt Leukemia
por: Renzi, Samuele, et al.
Publicado: (2023) -
Myeloproliferative neoplasm with eosinophilia and T-lymphoblastic lymphoma with ETV6–LYN gene fusion
por: Telford, N, et al.
Publicado: (2016) -
Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders
por: Mesa, Ruben A
Publicado: (2007) -
Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms
por: Barcelos, Michelle Maccarini, et al.
Publicado: (2011)